The effectiveness of gabapentin in treating overactive bladder: a quasi-experimental study
Immunopathologia Persa · 04.12.2023 · 10 (1) · e40574
DOI: 10.34172/ipp.2023.40574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunopathologia Persa, online erschienen am 04.12.2023. Verfasst von Malik Ayyad und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Overactive bladder (OAB) is a common condition in urology that affects individuals of various ages and genders, significantly impacting their quality of life.
Objectives
The study aimed to examine the effectiveness of gabapentin in treating OAB in Jordan. Patients and Methods: This study was conducted at a private clinic in Jordan between 2020 and 2022. It utilized a one-group pre- and post-test design involving 50 patients. The intervention involved administering gabapentin at a daily dose of 400 mg. The effectiveness of gabapentin was evaluated using the overactive bladder symptom score (OABSS) questionnaire, administered before and after six weeks of gabapentin administration.
Results
The study sample consisted of 50 patients aged between 45 and 85 years, with a mean age of 65.2 years. After the treatment, all individual variables, such as urgency, frequency, nocturia, and urgency incontinence, showed significant reductions compared to the pre-intervention values. The mean total OABSS significantly decreased from 14.6 before to 6.8 after the intervention. The paired t test yielded a result of 9.84 with a P value of less than 0.001, indicating a statistically significant improvement.
Conclusion
The noteworthy improvement in OABSS scores, urgency, nocturia, frequency of micturition, and urge incontinence observed in this study suggests that gabapentin could have a role as a treatment option for OAB patients.
Zitieren
APA
Ayyad, M., Ayaad, O., Alkhatatbeh, H., Sawaqed, F., Al-Rawashdeh, S., & Qaddumi, B. (2023). The effectiveness of gabapentin in treating overactive bladder: a quasi-experimental study. Immunopathologia Persa, 10(1), e40574. https://doi.org/10.34172/ipp.2023.40574
Vancouver
Ayyad M, Ayaad O, Alkhatatbeh H, Sawaqed F, Al-Rawashdeh S, Qaddumi B. The effectiveness of gabapentin in treating overactive bladder: a quasi-experimental study. Immunopathologia Persa. 2023;10(1):e40574. doi:10.34172/ipp.2023.40574
BibTeX
@article{Ayyad2023,
author = {Ayyad, Malik and Ayaad, Omar and Alkhatatbeh, Hassan and Sawaqed, Fadi and Al-Rawashdeh, Samer and Qaddumi, Bayan},
title = {The effectiveness of gabapentin in treating overactive bladder: a quasi-experimental study},
journal = {Immunopathologia Persa},
year = {2023},
volume = {10},
number = {1},
pages = {e40574},
doi = {10.34172/ipp.2023.40574}
}
EUVIMED